Continuous Monitoring of Glycemic Variability to Predict Dys- and Hyperglycemia in Asymptomatic Type 1 Diabetes
Sponsor: Breakthrough T1D
Listed as NCT05777330, this NA trial focuses on Type1 Diabetes Mellitus and remains actively recruiting participants. Sponsored by Breakthrough T1D, it has been updated 9 times since 2023, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Oct 2025 — Present [monthly]
Recruiting NA
-
Sep 2025 — Oct 2025 [monthly]
Recruiting NA
-
Jun 2025 — Sep 2025 [monthly]
Recruiting NA
-
May 2025 — Jun 2025 [monthly]
Recruiting NA
-
Sep 2024 — May 2025 [monthly]
Recruiting NA
▶ Show 4 earlier versions
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Dec 2023 — Jul 2024 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jun 2023 — Dec 2023 [monthly]
Not Yet Recruiting NA
-
Apr 2023 — Jun 2023 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Breakthrough T1D
- Universitair Ziekenhuis Brussel
For direct contact, visit the study record on ClinicalTrials.gov .